The cost of chemotherapy is very influential, and different treatment regimens are being explored for each type of cancer. Conclusion: This study underscores the important role of chemotherapy drugs, pharmaceutical costs, and medical devices in driving the overall cost of...
For lung cancer in particular, treatment[4] typically involves one or more of the following options, alone or in combination: surgery which can cost[5]$15,000or more;chemotherapy, which can cost$10,000 -$200,000or more;radiation therapy, which can cost$10,000-$50,000or more; and/or ...
Discover the high costs involved in cancer treatment such as chemotherapy & other treatments. Explore the challenges of patients & families.
Sensitivity analyses demonstrated that the cost-effectiveness (CEA) of alternating chemotherapy was greatest when treatment was given on an outpatient basis. The results of ... None - 《Lung Cancer》 被引量: 44发表: 1990年 Cost-effectiveness analysis of serplulimab combined with chemotherapy in ...
Polychemotherapy was found to be more effective than best supportive care, but was also more costly and had a lower value score. Because of its cost utility and its higher value, best supportive care should not be discarded as an alternative for the treatment of NSCLC....
Second-line treatment for NSCLC is more cost-effective with docetaxel than with pemetrexed. Both strategies have acceptable cost-effectiveness ratios compared with commonly used and reimbursed regimens for advanced NSCLC. 展开 关键词: Non-small cell lung cancer Second-line chemotherapy Pemetrexed ...
Cost analysis of hospital treatment—two chemotherapic regimens for non-surgical non-small cell lung cancer - ScienceDirect Study objectives: compare the costs of two regimens of chemotherapy. Apply weighted costs to an economic model in a hospital perspective. Design: prospecti... A Vergnenègre ...
Cost effective analysis of chemotherapy treatment: A study of cancer patients The present study was carried out to investigate the effectiveness of chemotherapy by monitoring the Quality of Life index of cancer patients. A sample of ... M Atif,Q Zaman,M Iqbal,... - 《Life Science Journal》 ...
Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis. Multidrug resistance (MDR) is a major problem in lung cancer. (99m)Tc-methoxyisobutylisonitrile ((99m)Tc-MIBI) has been demonstrated to be a noninvasive...
levels of lung cancer patients were evaluated by enzyme-linked immunosorbent assay using a monoclonal antibody N45.1 during radiotherapy and chemotherapy. An... K Umehara,M Endoh,T Miyase,... - 《Febs Letters》 被引量: 0发表: 1997年 New Prognostic Score Based on Treatment Outcome of Patients...